arstechnica.com
May 06, 2025
Article Bias: The article discusses the appointment of Vinay Prasad, a controversial figure known for his criticism of COVID-19 public health measures, to a significant role at the FDA, highlighting both supportive and critical perspectives on his views and implications for vaccine regulation under the new administration.
Social Shares: 163
ð― Libertarian <â> Authoritarian ð:
ð Opinion:
ðģ Political:
ðī Anti-establishment <â> Pro-establishment ðš:
â Uncredible <â> Credible â :
ð§ Rational <â> Irrational ðĪŠ:
ðŽ Scientific <â> Superstitious ðŪ:
ðĪ Individualist <â> Collectivist ðĨ:
ðē Speculation:
ð Low Integrity <â> High Integrity âĪïļ:
2024 © Helium Trades
Privacy Policy & Disclosure
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.